Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes

This publication has 26 references indexed in Scilit:

• Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1
  Virology, 2006
• Demystifying FluMist, a new intranasal, live influenza vaccine.
  Cleveland Clinic Journal of Medicine, 2003
• Sequence Analysis of the Washington/1964 Strain of Human Parainfluenza Virus Type 1 (HPIV1) and Recovery and Characterization of Wild-Type Recombinant HPIV1 Produced by Reverse Genetics
  Virus Genes, 2002
• Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States
  The Pediatric Infectious Disease Journal, 2001
• Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media
  New England Journal of Medicine, 1999
• Pediatric Hospitalizations for Croup (Laryngotracheobronchitis): Biennial Increases Associated with Human Parainfluenza Virus 1 Epidemics
  The Journal of Infectious Diseases, 1997
• Epidemiology and Clinical Impact of Parainfluenza Virus Infections in Otherwise Healthy Infants and Young Children < 5 Years Old
  The Journal of Infectious Diseases, 1997
• The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogenous
  Virology, 1992
• Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses
  Virus Research, 1988
• A Longitudinal Study of Respiratory Viruses and Bacteria in the Etiology of Acute Otitis Media with Effusion
  New England Journal of Medicine, 1982